Background and Purpose-The study aimed to assess whether onset headache is an ominous sign in patients with first-ever ischemic stroke. Methods-A large population of ischemic stroke patients was obtained from the Taiwan Stroke Registry. Stroke subtypes were classified by the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. On the basis of the International Classification of Headache Disorders, second version, onset headache was defined as a new headache that developed at the onset of ischemic stroke. Clinical features and impact on stroke outcomes, including in-hospital stroke in evolution, changes in National Institutes of Health Stroke Scale on discharge, and Barthel index and modified Rankin scale ≤6 months after stroke were compared between those with and without onset headache. Results-Among 11 523 patients with first-ever ischemic stroke, 848 had onset headache (7.4%). Patients with specific cause, large-artery atherosclerosis, or cardioembolism were more likely to have onset headache. Patients with onset headache were younger, predominantly female, and more likely to have posterior circulation ischemic lesions. Compared with patients without onset headache, those with onset headache had a lower frequency of stroke in evolution (4.5% versus 6.7%; adjusted relative risk, 0.64; 95% confidence interval, 0.52-0.79), greater improvement in National Institutes of Health Stroke Scale score on discharge (0.08 versus −0.20; P=0.02), higher mean Barthel index scores (86.5±20.0 versus 83.9±23.3; adjusted difference, 1.43; 95% confidence interval, 0.28-2.89), and a lower frequency of modified Rankin scale higher than 2 (27.6% versus 31.5%; adjusted relative risk, 0.85; 95% confidence interval, 0.72-0.95) at 1-month follow-up. There was also a trend for better functional outcome in 3-and 6-month follow-ups. Conclusions-By adopting standard classification criteria, this large-scale study demonstrated that onset headache was associated with modest but significantly better outcomes after ischemic stroke. (Stroke. 2013;44:1852-1858.)
H eadache that accompanies ischemic stroke is a common symptom that is considered an ominous sign by healthcare professionals treating acute ischemic stroke.
1,2 Very few small-scale studies have examined the clinical impact of stroke-related headache, and their results are inconsistent, from no specific impact to prediction of poor outcome. [1] [2] [3] [4] The clinical significance of stroke-related headache remains uncertain because of the absence of systematic studies on large populations of stroke patients. On the basis of the International Classification of Headache Disorder, 2nd edition (ICHD-2), 5 headache attributed to ischemic stroke (code 6.1.1) is specified as any new acute headache that develops simultaneously with or in very close temporal relation to signs of ischemic stroke.
Stroke-related headache can be grouped into 3 types: sentinel headache (headache before stroke onset), onset headache (headache at stroke onset), and late-onset headache (headache after stroke onset). [6] [7] [8] [9] [10] [11] [12] Most previous studies do not specify these differences and as such, the frequencies of stroke-related headache vary from 8% to 34%. [1] [2] [3] [4] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In fact, stroke-related headache at different time points may result from different mechanisms and may have varying clinical effects. A large sample of patients with stroke-related headache in a well-defined time frame and a systematic follow-up of clinical features and outcomes are required to delineate the clinical impact of stroke-related headaches. The present study sought to investigate the prevalence of onset headache in patients with first-ever ischemic stroke and assess its clinical significance using a nationwide prospective registration of stroke patients.
Methods

Data Source
The Taiwan Stroke Registry (TSR) was a government-funded project that identified acute stroke admissions. Formally launched on August 1, 2006 , it involved 39 academic and community hospitals diffusely covering the entire country, with 4 steps of quality control to ensure the reliability of entered data. All data were compiled prospectively by TSR-trained neurologists and study nurses, and all enrolled patients were visited by physiatrists, who started rehabilitation within 72 hours after admission. More than 42 000 patients with stroke were registered when the present study was undertaken. Approval of TSR as a human study protocol was obtained from the institutional review board of each participating hospital, and all subjects provided signed informed consents and permission for follow-up.
The data collection, quality-assurance processes, and preliminary results of the stroke patient population in the TSR have been detailed elsewhere. 19 In brief, preadmission medical and medication histories, stroke risk factors, clinical, laboratory and neuroradiological findings, interventions, and hospital course, including deterioration and outcome measures, were recorded in the TSR. Infarct locations were documented based on computed tomography and MRI findings and separated into anterior and posterior circulation territories. The anterior circulation territory was divided into the anterior cerebral artery and the middle cerebral artery territories, whereas the posterior circulation territory was divided into several parts, including the cortex supplied by the posterior cerebral artery, thalamus, midbrain, pons, medulla, and cerebellum. Ischemic stroke subtypes were classified according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria: large-artery atherosclerosis, small-vessel occlusion, cardioembolism, specific causes, and undetermined causes. 20 National Institutes of Health Stroke Scale (NIHSS) score was recorded in all patients on admission and on discharge. Investigators who rated the NIHSS were certified by the Taiwan Stroke Society and trained for data entry through a Web-based TSR database system. In addition, the Barthel index score and modified Rankin Scale (mRS) were recorded at 1, 3, and 6 months after the stroke at the outpatient clinic or through structured telephonic interview.
A total of 42 883 stroke patients were included in the TSR database when the present study was initiated. Only adults (≥18 years old) with first-ever ischemic stroke and confirmed ischemic lesions by neuroimaging, regardless of whether or not the clinical symptoms remitted spontaneously, were included. From the preliminary study population of 16 313, patients with difficulty in expressing headache (n=4790) were excluded. They were defined as patients with scores of either >0 (consciousness disturbance) in NIHSS items 1A, 1B, and 1C (level of consciousness), or ≥2 (severe aphasia) in item 9 (best language). The final sample consisted of 11 523 patients, accounting for 70.6% of the preliminary population with first-ever ischemic stroke ( Figure) . Their admission NIHSS scores were significantly lower than the scores of those who were excluded (4.1±3.1 versus 15.5±8.5; P<0.0001)
Onset Headache of Ischemic Stroke
Onset headache was inquired from each patient via structured questionnaire based on the TSR protocol. On the basis of ICHD-2, 5 onset headache was defined as a new headache that developed at the onset of other neurological symptoms related to ischemic stroke.
Outcome Measures
Three outcome measures were analyzed: (1) the frequency of deterioration during hospitalization; (2) changes in NIHSS score from admission to discharge; and (3) Barthel index scores and mRS at 1, 3, and 6 months after stroke. An mRS≤2 was defined as good outcome.
Deterioration during hospitalization was prospectively recorded by the physician if the patient's neurological symptoms worsened with an increase of ≥4 points in NIHSS compared with that at admission. On the basis of the examination of neuroimaging and laboratory test, the causes of deterioration were classified into 3 groups: stroke in evolution, medical complications, and others. Stroke in evolution was defined as progressive worsening of infarction lesion-related neurological symptoms after excluding the possibility of medical problems. In these patients, herniation and hemorrhagic infarction were also recorded. Medical complications were defined as infection, electrolyte imbalance, or neurological worsening related to serious fluctuations in blood glucose level.
The mean change of NIHSS scores on admission and on discharge was used for short-term outcome evaluation. The Barthel index and proportions of mRS scores ≤2 at 1, 3, and 6 months after stroke onset were used to evaluate long-term outcome.
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hypertension, anterior and posterior infarct territory, stroke subtype, and recombinant tissue-type plasminogen activator treatment were controlled. The least squares means and standard errors of NIHSS scores were calculated using ANCOVA models to compare the mean change of scores from admission to discharge between groups, after adjusting for the same factors in the multivariable Poisson regression models. The value/degrees of freedom of deviance of the Poisson regression was ≈1.00, representing a high-level goodness of fit of the data.
Results
Demographic Data
Of the 11 523 adult patients with first-ever stroke, 848 (7.4%) had headache at stroke onset, whereas 10 675 did not ( Figure) . 
Vascular Territory
Patients with onset headache were more likely to have ischemia in the posterior circulation in both models before and after controlling for potential confounding factors (crude PR, 1.42; 95% CI,1.30-1.55; adjusted PR, 1.39; 95% CI, 1.27-1.51; Table 2 ). Further comparisons of different infarct localizations in relation to onset headache were shown in Table 3 . Patients with cerebellar infarction had the highest adjusted PR (adjusted PR, 2.24; 95% CI, 1.97-2.55), followed by those with posterior cerebral artery cortex (adjusted PR, 2.16; 95% CI, 1.86-2.50), medulla (adjusted PR, 2.14; 95% CI, 1.86-2.45), and multiple infarct locations in the posterior circulation territory (adjusted PR, 1.89; 95% CI, 1.65-2.16). In contrast, the middle cerebral artery territory had a lower frequency of onset headache (adjusted PR, 0.78; 95% CI, 0.72-0.85). The pons, midbrain, thalamus, and anterior cerebral artery territory were not associated with onset headache.
Outcome Analysis
Patients with onset headache had lower frequencies of stroke deterioration during hospitalization compared with those without onset headache (5.5% versus 8.4%; crude RR, 0.66; 95% CI, 0.49-0.88; adjusted RR, 0.62; 95% CI, 0.52-0.78) with stroke in evolution (4.5% versus 6.7%; crude RR, 0.68; 95% CI, 0.57-0.83; adjusted RR, 0.64; 95% CI, 0.52-0.79) and medical complications (0.4% versus 0.9%; crude RR, 0.38; 95% CI, 0.27-0.53; adjusted RR, 0.13; 95% CI, 0.08-0.21) accounting for the difference. The frequencies of herniation, hemorrhagic infarction, and in-hospital mortality did not differ between the 2 groups (Table 4) .
Of the study population, 85.9% (9896 of 11 523) completed the 6-month follow-up after stroke onset. After controlling for baseline scores and potential confounding factors for stroke prognosis, including age, sex, infarct location, stroke subtype, length of hospitalization, and recombinant tissue-type plasminogen activator treatment, the improvement in NIHSS scores on discharge (mean duration 11.3 days of stay) was greater in patients with onset headache than those without (mean NIHSS score change 0.08 versus −0.2, P=0.02; Figure I in the onlineonly Data Supplement). Among the groups of different lengths of hospitalization, patients with onset headache had significantly greater NIHSS improvement only in the group of >10 days hospitalization. After controlling potential confounding factors, the difference remained ( Table 5 ).
The scores of Barthel index were significantly higher in the headache group at 1-, 3-, and 6-month follow-ups. However, after adjusting for potential confounding factors and stroke subtypes, the difference was significant only at 1-month follow-up (Table 5 ). The proportion of patients with mRS≤2 in the onset headache group was higher than those in the nononset headache group at 1, 3, and 6 months, but the difference was significant only at 1-month follow-up. The difference was still significant after adjusting for potential confounding factors and stroke subtypes ( Table 4 ). The 4 major subgroups of ischemic stroke (eg, large artery, small artery, cardioembolism, and specific cause) showed similar trends in outcome analyses (online-only Data Supplement).
Discussion
The present study shows that the frequency of onset headache in patients with first-ever stroke is 7.4%, which is lower than those previously reported (8%-18%). [8] [9] [10] [11] The cause of this discrepancy may be because of the strict definition used in the present study, that is, only headache at the onset of stroke. In addition, this study adopts the ICHD-2 criteria and stresses new headache but not the usual headache. Similar to previous reports, this study suggests that patients with younger age and female sex are more likely to develop onset headache. 
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Infarctions in the posterior circulation territory are also more likely to be associated with onset headache than infarctions in other territories. Infarctions in the cerebellum, medulla, or posterior cerebral artery cortex are more likely to be associated with onset headache compared with other regions. The cerebellum and posterior cerebral artery cortex have been implicated in prior studies, 15, 16 but the medulla is being reported for the first time, in the present study. Although the cerebellum is insensitive to pain, the vertebral artery and posterior inferior cerebellar arteries that supply both the medulla and cerebellum are sensitive to pain. 21 Furthermore, the occipital cortex and trigeminal nucleus in the medulla are related to the migraine pain pathophysiology. 22, 23 Consistent with prior reports, the present study shows that the midbrain and pons are not associated with onset headache even though these 2 regions are also important for pain modulation. 22 Whether embolic stroke patients have a higher frequency of onset headache remains to be determined. 8, 9, 12, 15 The data here show that cardioembolism and large-artery arthrosclerosis have comparable frequencies of onset headache. Because small-vessel disease is associated with the lowest probability, the involvement of large vessels may be more important than the underlying causes (ie, thrombosis versus embolism).
The clinical impact of onset headache in patients with ischemic stroke is controversial. The results here show that ischemic stroke patients with onset headache have a slightly but significantly lower frequency of stroke in evolution during hospitalization (4.5% versus 6.7%; adjusted RR, 0.64; 95% CI, 0.52-0.79). Moreover, ischemic stroke presenting with onset headache has a better outcome based on improvements in NIHSS scores on discharge after an average of 11.3 days of hospitalization, higher Barthel index at 1-, 3-, and 6-month follow-up, and higher proportion of patients with mRS≤2 at 1-month follow-up. The finding that onset headache is accompanied by better outlook is consistent across 3 different outcome measures. Because previous stroke history and baseline NIHSS score at stroke onset are predictors of hospital disposition and long-term outcomes, 20, [24] [25] [26] the present study has only included first-ever stroke patients and has controlled baseline severity when compared with outcomes.
Although onset headache is suspected to be a dangerous symptom in stroke patients, very few studies, mostly with small sample sizes, have reported outcome evaluations, and report either no difference or poorer outcomes in patients with strokerelated headache. Salgado and Ferro 4 report no difference in the functional outcome between lacunar stroke patients with and those without headache in a 6-month follow-up period. Similar results have been reported by Jørgensen et al. 3 In contrast, Arboix et al 2 have shown that lacunar stroke patients with headache have lower frequencies of symptomfree rate on discharge compared with those without headache. Leira et al 1 also note that 83.6% of ischemic stroke patients with headache had stroke progression during hospitalization, much higher than the 19.6% of patients without headache. The study by Leira et al. also noted that patients with headache have higher mean NO metabolites in the cerebrospinal fluid. 1 The apparent discrepancy between this and other studies must be resolved. Nonetheless, the current study has recruited stroke patients from multiple centers using a well-characterized definition for onset headache.
Different stroke pathophysiologies between patients with and those without onset headache may account for the discrepancy in outcomes. The mechanism underlying onset headache must be explored. The disturbance in blood flow or dilation of pain-sensitive collateral vasculature has long been suspected as a cause of onset headache. 7 It is also known that leptomeningeal arteries innervated by the trigeminal nerve are crucial for headache disorders. 23 The presence of leptomeningeal collaterals predicts improvement in clinical outcomes in patients treated with and without thrombolysis. 27, 28 The hypothesis of the present study is that the onset headache may be a clinical manifestation of leptomeningeal collaterals and can therefore predict good outcome in patients with ischemic stroke. However, more studies are warranted to confirm this.
The strengths of this study include (1) a very large sample that provides enough power to delineate the clinical correlates and impact of onset headache; (2) a standard and well-recognized stroke classification; and (3) high response rates of follow-up. However, some limitations should also be addressed. First, a history of prior headache, such as migraine or tensiontype headache was not routinely queried in the TSR study, and whether the headache at stroke onset was new was determined by the patients themselves. Coincident headaches or exacerbated primary headache disorders at stroke onset could not be completely excluded. Second, the profiles of onset headache were not recorded in this study, and it is not known whether certain headache profiles, such as headache pattern, severity, or locations, are related to stroke or its outcome. Third, late-onset headache was likewise not recorded. Thus, the possibility of differential impacts of headache on outcomes at different time points after stroke cannot be determined. Fourth, because participants had to report whether or not they had onset headache, their stroke severity tended to be mild (mean NIHSS 4.1). As such, even though the stroke patients included in this study accounted for 70.6% of the first-ever ischemic stroke of the total TSR samples, caution must be exercised in extrapolating the results to the entire stroke population. Last, multiple comparisons were used to examine the study outcomes. Although most of the measures showed similar trends, it should be noted that these measurements correlated with each other.
The present study demonstrates that patients with largeartery atherosclerosis and cardioembolism, especially in the posterior circulation territory, are more likely to have onset headache. Unlike in previous reports, the findings here indicate that in first-ever ischemic stroke patients, onset headache is associated with modest but significantly better outcomes ≤6 months poststroke, rather than being a dangerous symptom. It is postulated that the onset headache at stroke may be a phenotype of the presence of leptomeningeal collaterals in patients with ischemic stroke and should therefore be documented and assessed when treating stroke patients.
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